Published in Pharma Law Weekly, June 28th, 2005
The company also announced that it has received the necessary regulatory and ethics approvals from the individual countries' regulatory agencies to initiate the trial in the United Kingdom, Germany, Romania, Serbia and India. These individual country approvals are required in addition to clearance from the Medicines and Healthcare Products Regulatory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly